J. Carrero et al., ANTI-METATYPE ANTIBODY STABILIZATION OF FV-4-4-20 VARIABLE DOMAIN DYNAMICS, The Journal of biological chemistry, 271(19), 1996, pp. 11247-11252
Anti-metatype (anti-Met) antibodies are immunoglobulins that specifica
lly recognize and stabilize antibodies in their liganded or metatypic
state, but lack specificity for either the hapten or the unliganded an
tibody. Autologous anti-Met antibodies were previously observed in viv
o, suggesting that a metatypic autoantibody response could play a phys
iological role in the immune network, e.g. controlling the clearance o
f immune complexes from circulation. The first elicited anti-Met antib
odies were against the fluorescein-liganded high affinity murine anti-
fluorescein monoclonal antibody 4-4-20. The fluorescein-hapten system
has proved to be an invaluable tool for both the recognition and chara
cterization of the metatypic response by utilization of its spectral p
roperties. In this investigation, hydrostatic pressure measurements, i
n conjunction with fluorescence spectroscopy, were performed on the re
combinant Fv derivative (Fv 4-4-20) of the high affinity anti-fluoresc
ein monoclonal antibody 4-4-20 complexed to anti-Met antibodies to stu
dy the influence of anti-Met antibodies on Fv 4-4-20 intervariable dom
ain interactions. Anti-Met antibodies bound to liganded Fv 4-4-20 were
observed to cause a change in the fluorescence properties of fluoresc
ein that was not observed when anti-Met antibodies were bound to the l
iganded parent immunoglobulin. The variation of these spectral propert
ies upon addition of anti-Met antibodies was shown to be correlated wi
th dissociation of the variable domains in Fv 4-4-20 in response to it
s interaction with the anti-Met antibody. The ability to cause variabl
e domain dissociation was dependent on whether monoclonal or polyclona
l anti-Met antibodies were bound to the metatype. A model was proposed
that elucidated the interaction of anti-Met antibodies, polyclonal an
d monoclonal, with variable domains of the primary anti-antigen antibo
dy.